ASP4396

· Astellas Pharma Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP4396, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Find a Suitable Dose of ASP4396 in Adults With Solid Tumors [Phase 1]